Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seprafilm cuts adhesions by 45%

This article was originally published in Clinica

Executive Summary

Genzyme's Seprafilm cut the incidence of surgical adhesions from 94% to 49% in a major study presented at the American College of Surgeons annual clinical congress (October 22nd-27th). The cleverly designed trial was described as a "landmark" by Dr Thomas Hunt during discussion of the paper, which was clearly the highlight of Tuesday afternoon's research session. David Firn reports from New Orleans.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093851

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel